Zhengye Biotechnology Holding (ZYBT) Assets Average (2024 - 2025)
Zhengye Biotechnology Holding (ZYBT) reported Assets Average of $66.0 million for Q4 2025, down 4.43% year-over-year from $69.0 million in Q4 2024, and down 5.12% quarter-over-quarter from $69.6 million in Q2 2025.
Zhengye Biotechnology Holding (ZYBT) Assets Average (2024 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has 2 years of Assets Average data on file, last reported at $66.0 million in Q4 2025.
- Assets Average for Q4 2025 came in at $66.0 million, down 4.43% year-over-year; the trailing twelve-month figure through Dec 2025 was $66.0 million (down 4.43% YoY), and the FY2025 annual result was $65.0 million, down 5.12% from the prior year.
- Assets Average declined to $66.0 million in Q4 2025 per ZYBT's latest filing, from $69.6 million in the prior quarter.
- Over five years, Assets Average peaked at $69.6 million in Q2 2025 and troughed at $66.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 40.39 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 15.32 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 7.30 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 552.96 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 4.77 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.29 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 3.37 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 2.21 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.29 Bn |
| 10 | Zhengye Biotechnology Holding | 5.49 Mn | 6.20 Mn | - | 65.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 65.99 Mn |
| Jun 30, 2025 | 69.56 Mn |
| Dec 31, 2024 | 69.05 Mn |